Literature DB >> 10027392

Microvessels from Alzheimer's disease brains kill neurons in vitro.

P Grammas1, P Moore, P H Weigel.   

Abstract

Understanding the pathogenesis of Alzheimer's disease is of widespread interest because it is an increasingly prevalent disorder that is progressive, fatal, and currently untreatable. The dementia of Alzheimer's disease is caused by neuronal cell death. We demonstrate for the first time that blood vessels isolated from the brains of Alzheimer's disease patients can directly kill neurons in vitro. Either direct co-culture of Alzheimer's disease microvessels with neurons or incubation of cultured neurons with conditioned medium from microvessels results in neuronal cell death. In contrast, vessels from elderly nondemented donors are significantly (P<0.001) less lethal and brain vessels from younger donors are not neurotoxic. Neuronal killing by either direct co-culture with Alzheimer's disease microvessels or conditioned medium is dose- and time-dependent. Neuronal death can occur by either apoptotic or necrotic mechanisms. The microvessel factor is neurospecific, killing primary cortical neurons, cerebellar granule neurons, and differentiated PC-12 cells, but not non-neuronal cell types or undifferentiated PC-12 cells. Appearance of the neurotoxic factor is decreased by blocking microvessel protein synthesis with cycloheximide. The neurotoxic factor is soluble and likely a protein, because its activity is heat labile and trypsin sensitive. These findings implicate a novel mechanism of vascular-mediated neuronal cell death in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027392      PMCID: PMC1850001          DOI: 10.1016/S0002-9440(10)65280-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Production of neurotoxic factors by brain endothelium in Alzheimer's disease.

Authors:  P Grammas; T R Botchlet; P Moore; P H Weigel
Journal:  Ann N Y Acad Sci       Date:  1997-09-26       Impact factor: 5.691

2.  The blood-brain barrier in Alzheimer's disease and normal aging.

Authors:  C L Masters; K Beyreuther
Journal:  Neurobiol Aging       Date:  1988 Jan-Feb       Impact factor: 4.673

3.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

4.  Does superoxide underlie the pathogenesis of hypertension?

Authors:  K Nakazono; N Watanabe; K Matsuno; J Sasaki; T Sato; M Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.

Authors:  R N Kalaria; S I Harik
Journal:  J Neurochem       Date:  1989-10       Impact factor: 5.372

7.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

8.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

Authors:  G D Schellenberg; T D Bird; E M Wijsman; H T Orr; L Anderson; E Nemens; J A White; L Bonnycastle; J L Weber; M E Alonso
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

9.  Blood brain barrier in ageing and Alzheimer's disease.

Authors:  D C Davies; J A Hardy
Journal:  Neurobiol Aging       Date:  1988 Jan-Feb       Impact factor: 4.673

10.  Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease.

Authors:  M A Dorheim; W R Tracey; J S Pollock; P Grammas
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

View more
  28 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  Pigment epithelium-derived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1/2 and induction of Bcl-2.

Authors:  A Sanchez; D Tripathy; X Yin; J Luo; J Martinez; P Grammas
Journal:  Neurosci Res       Date:  2011-09-17       Impact factor: 3.304

3.  Multiple neurotrophic effects of VEGF on cultured neurons.

Authors:  Alma Sanchez; Suchin Wadhwani; Paula Grammas
Journal:  Neuropeptides       Date:  2010-04-28       Impact factor: 3.286

4.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons.

Authors:  Alma Sanchez; Debjani Tripathy; Paula Grammas
Journal:  Neuropeptides       Date:  2009-06-03       Impact factor: 3.286

Review 5.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

6.  RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.

Authors:  Debjani Tripathy; Lakshmi Thirumangalakudi; Paula Grammas
Journal:  Neurobiol Aging       Date:  2008-04-28       Impact factor: 4.673

Review 7.  The science of stroke: mechanisms in search of treatments.

Authors:  Michael A Moskowitz; Eng H Lo; Costantino Iadecola
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

Review 8.  Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

Authors:  William A Banks
Journal:  Adv Drug Deliv Rev       Date:  2011-12-17       Impact factor: 15.470

9.  Cerebrovascular expression of proteins related to inflammation, oxidative stress and neurotoxicity is altered with aging.

Authors:  Debjani Tripathy; Xiangling Yin; Alma Sanchez; Jinhua Luo; Joseph Martinez; Paula Grammas
Journal:  J Neuroinflammation       Date:  2010-10-11       Impact factor: 8.322

10.  Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.

Authors:  Lakshmi Thirumangalakudi; Haripriya Vittal Rao; Paula Grammas
Journal:  Neurosci Lett       Date:  2009-01-21       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.